baber/WOPTO huggingface dataset:
Patent NZ-306718-A (NZ)
Title: Antibody purification by low-ph hydrophobic interaction chromatography (lphic)
Inventor: RINDERKNECHT ERNST H
IPC: C07K16/00
Filed: 1996-04-05
Abstract: The invention provides an antibody which comprises a linear V H -C H 1-V H -C H 1 heavy chain fragment associated with two light chain fragments, wherein the C-terminus of C H  1  is joined directly to the N-terminus of V H  at the Fd-Fd junction of the heavy chain fragment, a nucleic acid encoding the heavy chain fragment, and a method for the preparation of said antibody.
Patent NZ-333200-A (NZ)
Title: Self-setting yarn comprised of two components having different stress relaxation responses
Inventor: WILKE ARNOLD E
IPC: D02G3/24
Filed: 1998-12-07
Abstract: The disclosure relates to a self-set yarn comprising at least one yarn comprised of a majority of multi-component fibers having a first polymer component with a first stress relaxation and, longitudinally co-extensive therewith, a second polymer component with a second stress relaxation response, said first polymer component and said second polymer component arranged in a side-by-side or eccentric sheath/core fashion; wherein said yarn is permanently twisted to at least 1tpi, and wherein said first stress relaxation response and second stress relaxation response are sufficiently different to produce at least a 10% decrease in length of said yarn.
Patent NZ-335804-A (NZ)
Title: Bleaching formulation comprising formamidinesulfinic acid, an anti-coating agent and silica
Inventor: JAKOB HARALD
IPC: D06L4/30
Filed: 1999-05-17
Abstract: The dry powder composition comprises a stabilising amount of formamidinesulfinic acid, 0.05 to 4 wt% of an anti-coating agent comprising at least one member selected from the group consisting of a polycarboxylate, a polyphosphoric acid and citric acid, and 0.001 to 5 wt% of finely divided silica.  The preferred anti-coating agents are complexing agents that are soluble in water. This composition has improved flow and stability properties and may be used for the bleaching of paper or textiles.
Patent NZ-336663-A (NZ)
Title: Use of kraft lignin or lignin sulphonate when reacted with oxygen, air or other oxidizing agent forming an intermediate product which can eventually be converted to form a macromolecule polymerizate
Inventor: VIIKARI LIISA
IPC: C08L97/02
Filed: 1998-01-14
Abstract: An intermediate product for the preparation of polymerisates from lignin derivatives obtained from the cellulose industry. The intermediate product is produced by treating the lignin derivatives with enzymes capable of oxidising phenol in the presence of oxidising agents. The lignin derivatives are subjected to the enzymatic treatment for more than 3 hours in the presence of air, or they are subjected to an enzymatic treatment for more than 10 min, whereby air or oxygen is introduced. The lignin polymers obtained from the polymerisation of lignin derivatives performed in the presence of active intermediate products are suited for use in the production of binding agents for wood materials.
Patent NZ-336852-A (NZ)
Title: Production of lactic acid from whey proteins where electrodialysis causes less biofouling of the electrodialysis membrane
Inventor: NORDDAHL BIRGIR
IPC: C12R1/225
Filed: 1997-12-22
Abstract: A process for fermentative production of lactic acid from a sugar-containing fermentation liquid in a fermentor by means of lactic acid-forming bacteria, in which whey protein is present or is added as a nutrient substrate for the lactic acid-forming bacteria, wherein at least one protease is added to the fermentor during the fermentation, so that hydrolysis of protein to amino acids takes place simultaneously with the fermentation of sugar into organic acid, and wherein lactic acid resulting from the fermentation is isolated from the fermentation liquid. Ammonia is preferably added to result in the formation of ammonium lactate, and lactic acid is preferably isolated by a process comprising ultra filtration, ion exchange, conventional electrodialysis and electrodialysis with bipolar membranes.
Patent NZ-502603-A (NZ)
Title: Multitransducer microphone arrays with signal processing for high resolution sound field recording
Inventor: POLETTI MARK ALISTAIR
IPC: H04R3/00
Filed: 2000-02-02
Abstract: A plurality of transducers 31 are arranged in a planar circular array, each transducer producing an output signal M0,_,Mn-1 in response to a sound wave of a sound field impinging on the transducer.  The digital signal processor 33 calculates the Fourier transform of the signals output by the transducers to specify the sound waves as a plurality of components, which are equalized by the filter arrangement 34 to flatten the apparent frequency response of the array over a portion of the audio band.  The network 35 combines the equalized components into audio signals that can be recorded for multichannel surround sound (six channel) reproduction.
Patent NZ-505396-A (NZ)
Title: Synthetic stucco system for a building
Inventor: PHILLIPS JERRY S
IPC: C04B41/48
Filed: 1998-12-02
Abstract: A synthetic stucco comprises a building having at least one wall with a base substrate having an interior surface and an exterior surface and a first coating comprising a polyurea, polyurethane-polyurea hybrid or a combination thereof on the interior surface or the external surface of the base substrate.
Patent NZ-506811-A (NZ)
Title: Blister pack with blisters in cooperating rows being rotationally symmetrical about longitudinal axis, for inhalation device
Inventor: TIEDEMANN VOLKER
IPC: B65D83/04
Filed: 1999-03-16
Abstract: A blister pack unit for a powder inhaler, comprising a body which includes a plurality of surfaces which each includes a plurality of blisters (21, 22) containing powder containing medicament and are rotationally symmetrically disposed about an imaginary axis.
Patent NZ-508366-A (NZ)
Title: Neisseria meningitidis antigens and compositions
Inventor: GALEOTTI CESIRA
IPC: C12P21/08
Filed: 1999-04-30
Abstract: Proteins from Neisseria meningitidis that are useful antigens for vaccines and/or diagnostics, including the amino acid sequences and the corresponding nucleotide sequences.
Patent NZ-509462-A (NZ)
Title: Method of removing and preventing the buildup of contaminants in papermaking processes
Inventor: O'NEAL OLLIE
IPC: B08B3/08
Filed: 1999-06-18
Abstract: Described is a method for removing and preventing the buildup of contaminants in papermaking wet press felts and on forming wires using a cleaning solution which contains at least one acidic cleaning compound and peracetic acid.
Patent NZ-509894-A (NZ)
Title: A "T" or "Y" shaped intravaginal device suitable for delivery of pharmaceuticals such as progesterone
Inventor: WYLLIE MARK ANDREW
IPC: A61D7/00
Filed: 2001-02-09
Abstract: It is important to have geometry retainable devices, such as intra-vaginal retention devices for pigs, to have certain features. Chief amongst these are the capability of safely retaining the device within the body of an animal, and the capability for the device to be withdrawn (if desired) without discomfort or tissue harm to the recipient animal. The device disclosed attains this by having an elongate body, at least in part, limp in character. Also, the device has at least two wings that are capable in extending outwardly from the body (in a "T" or "Y" shape) to help retain the device inside the animal.  The device is constructed of a material having a resilient memory greater than that of nylon, such as poly (å-caprolactone) or poly (å-caprolactone) based matrix.
Patent NZ-513744-A (NZ)
Title: Method and arrangement for the continuous manufacture of profiled lignocellulose-containing board or strip-like products
Inventor: ERIKSSON N LENNART
IPC: B27N3/08
Filed: 2000-01-31
Abstract: In a method and an arrangement for continuously producing profiled, lignocellulose-containing board or strip-like products the fibre material is disintegrated into particle and/or fibre form, which are then dried, glue-coated and formed into a fibre mat (3). This is pressed into a board or strip-like product (4) while injecting steam. Prior to pressing, the fibre mat (3) is given a surface profile, which is maintained during the steam injection process, whereupon the surface of the board of strip-like product is compressed with this profile.
Patent NZ-514095-A (NZ)
Title: Amide compounds and medicinal use thereof
Inventor: USHIO HIROYUKI
IPC: C07D401/12
Filed: 2000-02-10
Abstract: The present invention relates to a compound of the formula <CHEM> wherein R<1> is substituted aryl, heteroaryl and the like, R<2> and R<3> are hydrogen, alkyl, halogen, hydroxyl group and the like, Q is N, CH and the like, W is hydrogen, alkyl, hydroxycarbonylalkyl and the like, X is halogen, cyano, nitro, amino and the like, X' is hydrogen, halogen, cyano, nitro, and Y is alkyl, hydroxyl group, alkoxy, mercapto and the like and a salt thereof, and a medicine containing the said compound. The compound of the present invention shows a superior inhibitory effect on activated lymphocytes proliferation and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.
Patent NZ-514425-A (NZ)
Title: Compositions based on chondroitin sulphate and chitosan for preventing or treating rheumatic disorders by general administration
Inventor: DERRIEU GUY
IPC: A61P19/00
Filed: 2000-03-22
Abstract: Described is a preparation comprising: (a) from 1 to 50% by weight relative to the total weight of the preparation, of at least one compound chosen from chondroitin sulphates and their salts, and (b) from 1 to 66% by weight, relative to the total weight of the preparation, of at least one compound chosen from chitosan, its salts, its derivatives and the salts of these derivatives. The preparation is used for preparing a composition for the prevention or treatment of rheumatic conditions by the general route, and in particular, for the prevention or treatment of degenerative arthropathies.
Patent NZ-515426-A (NZ)
Title: Professional services offer, bid, quote and acceptance online system
Inventor: LUCAS JOHN GARTH
IPC: G06F19/00
Filed: 2001-11-13
Abstract: A system stores professional services provider details in a provider database.  Services requestors can make remote free text requests to the central processor, the requests and requestor details being stored in a requestor database.  In accordance with a category into which the request is nominated by the requestor in accordance with advice from the processor, the requests are notified to appropriate providers who may respond by free text entries into the database to tender to provide services to satisfy the request.
Patent NZ-517324-A (NZ)
Title: 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-YL)- dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors
Inventor: ALLERTON CHARLOTTE MOIRA NORFO
IPC: A61P15/12
Filed: 2000-10-04
Abstract: Compounds  of  formula (I), which are  useful  in  the curative  and prophylactic treatment of a medical  condition for   which   inhibition  of  a  cyclic   guanosine   3',5'- monophosphate phosphodiesterase (e.g. cGMP PDE5) and  having utility   in   therapeutic  areas  such  as  erectile   male dysfunction (MED) are disclosed, wherein R1, R2, R3, R4  and X are as described in the specification.
Patent NZ-523330-A (NZ)
Title: Pharmaceutical compositions of estrogenic agents
Inventor: BENJAMIN ERIC JOEL
IPC: A61K47/26
Filed: 2001-06-29
Abstract: A pharmaceutical carrier or excipient systems and oral pharmaceutical formulations comprising as an active ingredient raloxifene, amoxifen, droloxifene, arzoxifene, or CP 336156, or analogs thereof, or a compound of formulae (I) or (II) or a pharmaceutically acceptable salt thereof; and excipients chosen from pharmaceutical fillers, glidants, lubricants, wetting agents and antioxidants is disclosed, wherein: Z is a moiety selected from the group of formulae (a, b or c); R1 is selected from H, OH or the C1-C12 esters alkyl ethers thereof, benzyloxy, or halogen; or C1-C4 halogenated ethers; R2, R3, R4, R5, and R6 are H, OH or C1-C12 esters or alkyl ethers thereof, halogens, or C1-C4 halogenated ethers, cyano, C1-C6 alkyl, or CF3, with the proviso that, when R1 is H, R2 is not OH; Y is the moiety of formula (d), wherein R7 and R8 are alkyl or concatenated together to form an optionally substituted, nitrogen-containing ring.
Patent NZ-526609-A (NZ)
Title: Use of a mixture of EPA and DHA in the preparation of a medicament for treating cardiac insufficiency and heart failure therapy
Inventor: GRANATA FRANCESCO
IPC: A61P9/10
Filed: 2002-01-16
Abstract: An essential fatty acid mixture comprising eicosapentaenoic acid ethyl ester (EPA) and docosahexaenoic acid ethyl ester (DHA) can be used in the preparation of a medicament useful for the prevention and treatment of a heart disease selected from chronic and acute cardiac insufficiency and heart failure. Preferably the medicament is suitable for combined therapy with another therapeutic agent selected from the group consisting of an ACE-inhibitor, a NEP-inhibitor, an ACE/NEP-inhibitor, an angiotensin II converting enzyme inhibitor, a diuretic, a positive inotropic drug, a phosphodieserase inhibitor, an arteriolar vasodilator, a venular vasodilator, a beta-blocker, a digitalis glycoside.
Patent NZ-526780-A (NZ)
Title: Modafinil compound and cyclodextrin mixtures
Inventor: JACOBS MARTIN J
IPC: A61K47/48
Filed: 2001-12-19
Abstract: A pharmaceutical composition comprising inclusion complex of a modafinil compound and a cyclodextrin is disclosed, wherein the modafinil compound has an aqueous solubility of at least 10mg/ml and the composition provides at least a 10% increase in the blood serum level of a modafinil compound in a mammal upon oral administration relative to the same amount of a modafinil compound in a solid oral dosage form.
Patent NZ-530783-A (NZ)
Title: Synthetic closure
Inventor: LAUER EDUARDO
IPC: B32B5/32
Filed: 2002-07-15
Abstract: By achieving an extruded, foamed core formed from plastic material peripherally surrounded and integrally bonded with a plurality of cooperating synthetic, plastic, extruded, outer layers, a unique, multi-component, multi-layer synthetic closure is stated to be provided which may be employed as a bottle closure or stopper for any desired product, whether the product is a liquid, a viscous material, or a solid distributed in a bottle or container and dispensed through the open portal of the container neck. The present invention is stated to achieve a mass producible, resilient, synthetic bottle closure which is employable for any desired bottle, including wine. By employing the present invention, a multi-component or multi-layer synthetic closure is attained which possesses physical properties substantially equal to or better than the physical properties found in cork material, which has caused such cork material to be the principal closure material for wine bottles.
Patent NZ-531892-A (NZ)
Title: A light trailer
Inventor: FRANKLIN WILLIAM EDWARD
IPC: B62D63/06
Filed: 2004-03-24
Abstract: A trailer includes a chassis frame, a drawbar 26 coupled to the chassis, lever means 20 pivotally coupled to the chassis and wheel mounting means 62, 63 coupled to the lever means. The wheel mounting means include axles 69, for mounting wheels 72, and create a fulcrum such that movement of the lever means 20 allows the chassis to be lowered to a loading position or raised to a towing position (see figures 15 A-E).
Patent NZ-532478-A (NZ)
Title: Methods for treating depression and other CNS disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram
Inventor: BUSH LARRY R
IPC: C07D307/78
Filed: 2002-11-05
Abstract: Compositions containing enantiomerically enriched (-)-desmethylcitalopram, (+)-didesmethylcitalopram, or (-)-didesmethylcitalopram or mixtures thereof in optimal ratios. Contrary to prior teachings, the enantiomerically enriched citalopram metabolites disclosed herein possess potent serotonin reuptake inhibitory activity, with minimal inhibitory effects on the reuptake of other known monoamines, e.g., norepinephrine (NE) or dopamine (DA). Also disclosed are methods for treating disorders, dysfunctions and diseases for which inhibition of serotonin reuptake is therapeutically beneficial such as depression.
Patent NZ-534542-A (NZ)
Title: Antibody-containing solutions in which the formation of degradation products and insoluble particles during storage and freeze/thaw cycles is inhibited by adding a sugar and surfactant respectively
Inventor: KIKUCHI JUN
IPC: A61K47/04
Filed: 2003-02-14
Abstract: An antibody-containing solution formulation including a nonreducing disaccharide or trisaccharide sugar as a stabilizer. The solution formulation is prepared without including any freeze-drying steps. The antibody is an anti-interleukin-6 receptor antibody or anti-HM1.24 antibody which it a chimeric, humanized or human antibody. Another stabilizer disclosed is a non-ionic surfactant.
Patent NZ-538234-A (NZ)
Title: Rotating sprinkler head with two outlet nozzles
Inventor: MCNEILL STUART HENRY
Filed: 2005-02-15
Abstract: A rotating sprinkler head 1 having first 6 and second 7 nozzles is disclosed. A water inlet 2 is connected to the nozzles via a channel to create two separate water jets out of the sprinkler head. The jet from the first nozzle contacts a deflector 8 to cause rotation of the second jet, spreading the water through an arc. Curved sides 18 adjacent the second nozzle create a flow of air behind the second jet to aid efficient movement of the second jet.
Patent NZ-541771-A (NZ)
Title: A wet shaving system with a shaving aid matrix and exfoliating elements
Inventor: KWIECIEN MICHAEL J
IPC: B26B21/44
Filed: 2004-03-16
Abstract: A wet shaving system comprises a blade member and a shaving aid composite. The shaving aid composite comprises a shaving aid matrix including a polymer and a shaving aid. The shaving aid composite also includes a plurality of exfoliating elements embedded in the shaving aid matrix.
Patent NZ-551582-A (NZ)
Title: Pyrrole compounds as inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto
Inventor: MARTINEZ-BOTELLA GABRIEL
IPC: C07F9/6558
Filed: 2005-05-13
Abstract: Disclosed are compounds of formula (I), wherein R1 is optionally substituted C1-6 aliphatic, and the remaining substituents are as defined in the specification. The compounds are potent and selective ERK2 inhibitors useful in the treatment of melanoma, colon cancer, pancreatic cancer, kidney carcinoma, lung cancer, ovarian cancer, or prostate cancer.
Patent NZ-552232-A (NZ)
Title: Profile-rail system
Inventor: SONDERMANN FRANK
Filed: 2006-12-20
Abstract: A profile rail system, for bridging joints, recesses and/or for an edge closure of flooring elements, comprises at least two mutually telescopic profiled rails. At least one of the rails has an undercut tongue and/or groove profiling on an end side configured to fit the tongue and groove profiling of flooring elements. The profiled rails can be connected to the flooring elements by tilting and pressing the tongue into the opposite groove.
Patent NZ-554496-A (NZ)
Title: Fan case reinforcement in a gas turbine jet engine
Inventor: CARDARELLA JAMES L
IPC: F01D21/04
Filed: 2005-09-20
Abstract: A method of reinforcing the fan case 1002 of a gas turbine engine, by the shrink interference fitting of a containment ring 1102 to the inside surface of the fan case 1002 with the containment ring 1102 held in place by the radially compressive forces applied to it by the fan case 1002.
Patent NZ-556471-A (NZ)
Title: 4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
Inventor: WYATT PAUL GRAHAM
IPC: A61K31/4155
Filed: 2006-01-20
Abstract: Disclosed are the methanesulfonic (mesylate) and acetic acid (acetate) addition salts of 4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide of formula (I). Also disclosed is a compound of formula (XI), an intermediate useful in the preparation of the compounds.
Patent NZ-560202-A (NZ)
Title: Optical disc recording medium, reproduction device and method and recording device and method for the recording medium
Inventor: FUJITA GORO
IPC: G11B7/004
Filed: 2006-02-07
Abstract: A recording apparatus for recording sub data to an optical-disk recording medium (100) is disclosed. The optical disk recording medium (100) includes a substrate (101) having main data recorded in the form of a combination of pits and lands on one side thereof and at least a reflective layer (102) and cover layer (103) stacked on the substrate by irradiating writing-power laser light (111) to portions corresponding to predetermined-length lands formed on the optical-disk recording medium to form marks on the reflective layer correspondingly to the predetermined-length lands. The recording apparatus comprises a recording means (OP) for recording the sub data to the optical-disk recording medium so that each of the marks is formed to such a size and depth by irradiating the writing-power laser light that the level of a reading signal will be raised at the portions where the marks are formed but will be lowered at the mark-formed portions in an optical-disk recording medium produced by physically transcribing the substrate shape of the above optical-disk recording medium. A playing apparatus for playing an optical-disk recording medium (100) is also disclosed. The optical-disk recording medium includes a substrate (101) having main data recorded in the form of a combination of pits and lands on one side thereof and at least a reflective layer(102) and cover layer (103) stacked on the substrate and to which sub data is recorded in the form of marks so formed on the reflective layer by irradiating writing-power laser light (111) to the reflective layer that the level of a reading signal will be raised at portions where the marks are formed by irradiating writing-power laser light but will be lowered at the mark-formed portions in an optical-disk recording medium produced by physically transcribing the substrate shape of the above optical-disk recording medium. The apparatus comprises a reading signal generating means for generating the reading signal by detecting a return part, from the optical-disk recording medium, of reading-power laser light having been irradiated to the optical-disk recording medium; a sub data detecting means for detecting the level of the sub data on the basis of the result of sampling the reading signal generated by the reading signal generating means at a predetermined sampling point; and a judging means for judging, based on a result of determining whether the value of the sub data detected by the sub data detecting means has a correct polarity, whether the optical-disk recording medium is a authenticated disk.
Patent NZ-563373-A (NZ)
Title: Method and composition for treating inflammatory disorders
Inventor: PERESWETOFF-MORATH LENA
IPC: A61K9/127
Filed: 2006-06-08
Abstract: Provided is a homogeneous pharmaceutical composition for the treatment of an inflammatory disorder comprising a mixture of an anti-inflammatory and/or antihistaminic active ingredient selected from the group comprising azelastine or a pharmaceutically-acceptable salt thereof, a steroid selected from alclometasone, beclometasone, budesonide, ciclesonide, clobetasol, clobetasone, defiazacort, dexamethasone, diflucortolone valerate, acetonide, fluocinonide, fluocortolone, fluprednidene, flurometholone, fluticasone, halcinonide, hydrocortisone, mometasone, prednisolone, rimexolone, triamcinolone and a pharmaceutically acceptable salt of any of these compounds in a pharmaceutically acceptable aqueous carrier, and a polar lipid liposome, provided that the active ingredient is not cetirizine, wherein the concentration of active ingredient in the aqueous carrier is substantially similar, whether located inside or outside the liposomal structures and varies by ±20% when comparing concentrations inside and outside of the liposomal structures.